chrisvoncsefalvay/vaers-outcomes huggingface dataset:
As of Friday, 6.24.22, I immediately started feeling extreme pressure in my head. Started with fever and rapid heartbeat. It continue getting worst, Friday, Saturday and Sunday. Ears ringing and felt like needle piercing through my eardrums. Then on Saturday morning, I got very thirsty, was drinking Vitamin water with B12. On Monday, you woke up and had very bad abdominal pain, the kind that put me in a fetal position with cold sweats like I have right now. It lasted 24 hours. So much pressure in my abdominal. I could drink a little water and it would hurt me even more. I had some kind of acid come up, like I was trying to get sick. It wasn't much, but then back to the fetal position all night. Drinking made it worst. I wasn't going to get the vaccination cause it caused me hurt the last time, but I needed this vaccination to travel. My head is still foggy, and I have cold sweats. I do not want to go to the hospital cause it's 5000.00 per hospital visit. To get in with my VA is like pulling teeth, so I am trying to decide if I need to go to the hospital. At this point I'm not sure what they can do, my heart has taking a beating, neck pain, feel like someone is sticking me in my left side of my chest.
Pt came in contact w/ rabid raccoon on 7/3/99;started rabies series on 7/17/99.7/18/99:Pt dvlped nausea,muscle aches, weakness,mild headache.Recv'd 2nd & 3rd shots w/ same sx. On 7/31 recv'd 4th shot & on 8/2 dvlped headache & weakness.
Pt recvd 1st dose of Hep B vax on 22MAY91 & immediately following vax pt devel burning & pain in lt upper arm @ site of inject; devel weakness of lt arm; presented to neurosurgeon & a dec pin prick sensation dx muscle weakness;
Report described elevated bilirubin in a 33 year old male who received hep A vaccine. This report was received from the vaccinee's wife and has not been verified by a physician or other health care professional. The vacinee's allergies, and medical history were not specified. In August 2000, the vaccinee reportedly received a subcutaneous injection of Havrix and an injection of hep B vaccine. It was not known whether the vaccinee ha dreceived previous doses of Havrix or hep B vaccine. Reportedly, the vaccinee subseuently developd an elevated bilirubin level, which he has currently. The consumer consulted a health care professional regarding the adverse event. Havrix was discontinued. As of 08/17/2001, the outcome of the adverse event was ongoing.
Follow up: Patient received casirivimab instead of intended COVID vaccine.  At 48-hr follow up, patient reported runny nose.  Patient received COVID vaccine on December 31
Headache, Myalgia, Arthralgia, Fever, NauseaVomiting, Chills/Fatigue Narrative:  Other Relevant History:
This spontaneous report was received from a Licensed Practical Nurse via a company representative concerning a 11 year old female patient. Pertinent Medical History and Drug Reactions/Allergies were not reported. On an unknown date, in approximately 2013, the patient was vaccinated with a dose of GARDASIL (Lot #, dose and route not reported). Concomitant vaccinations included meningococcal vaccine (unspecified) and Tdap (Lot #, doses and routes not reported). On an unspecified date in 2013 after receiving therapy with GARDASIL, the patient fainted (she refused to sit down) in the office, hit the wall, had a seizure and then fractured her skull. Subsequently, she was admitted to hospital where had a full recovery without further complications (dates unknown). There were no Lab Diagnostics Studies specified by the reporter. No further adverse event information was provided. Upon internal review seizure and skull fracture were considered to be medically significant. Additional information is not expected as reporter refused additional contact.
Mom reports: redness and warmth. 3 inch circumference at site of injection left thigh.
10 days after the shot I woke up with Bells palsy on my right side. Right side was getting better and yesterday (4/17)I woke with it on my left side. Too
Information has been received from a pharmacist concerning a patient who was supposed to receive ZOSTAVAX (Merck), "last week", on approximately 03-DEC-2009 was accidently vaccinated with VARIVAX (Merck) (lot not reported). No adverse effect was reported. At the time of the report, the outcome of the patient was not reported. Additional information has been requested.
Patient was paralysed by moderna; Osteomyelitis/ open wounds all the wayto the bone; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PARALYSIS (Patient was paralysed by moderna) and OSTEOMYELITIS (Osteomyelitis/ open wounds all the wayto the bone) in a male patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced PARALYSIS (Patient was paralysed by moderna) (seriousness criterion medically significant) and OSTEOMYELITIS (Osteomyelitis/ open wounds all the wayto the bone) (seriousness criterion medically significant). At the time of the report, PARALYSIS (Patient was paralysed by moderna) and OSTEOMYELITIS (Osteomyelitis/ open wounds all the wayto the bone) outcome was unknown.        The action taken with mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.   Treatment information was not provided.  Company Comment This spontaneous case concerns an unknown-years-old male patient, with  no medical history reported who experienced the unexpected seriousness criterion medically significant events of  paralysis and osteomyelitis unknown days after  a  dose of  mRNA-1273 bivalent vaccine.  The benefit-risk relationship of mrna-1273 bivalent vaccine is not affected by this report. Events seriousness was assessed based on medical judgement.   Most recent FOLLOW-UP information incorporated above includes: On 16-Nov-2022: Follow up received no new information.; Sender's Comments: Company Comment This spontaneous case concerns an unknown-years-old male patient, with  no medical history reported who experienced the unexpected seriousness criterion medically significant events of  paralysis and osteomyelitis unknown days after  a  dose of  mRNA-1273 bivalent vaccine.  The benefit-risk relationship of mrna-1273 bivalent vaccine is not affected by this report. Events seriousness was assessed based on medical judgement.
SO SLEEPY; HEAVY FEELING; FITFUL NIGHT; FELT BAD; CHILLS; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. As per procedure no follow-up will be requested for  this case. No concomitant medications were reported. On 2021, the subject experienced so sleepy. On 2021, the subject experienced heavy feeling. On 2021, the subject experienced fitful night. On 2021, the subject experienced felt bad. On 2021, the subject experienced chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from so sleepy, heavy feeling, fitful night, felt bad, and chills on 2021. This report was non-serious.
came down with a cold; first dose 11 Jan 2021; second dose 13 Mar 2021; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose 11 Jan 2021; second dose 13 Mar 2021) and NASOPHARYNGITIS (came down with a cold) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose 11 Jan 2021; second dose 13 Mar 2021). On an unknown date, the patient experienced NASOPHARYNGITIS (came down with a cold). On 13-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose 11 Jan 2021; second dose 13 Mar 2021) had resolved. At the time of the report, NASOPHARYNGITIS (came down with a cold) had resolved.            No treatment information was provided.   This case was linked to MOD-2021-034142 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-Apr-2021: Outcome of events and narrative updated; Patient received dose 2.; Reporter's Comments: Very limited information regarding this event (Nasopharyngitis) has been provided at this time. However, this report also refers to a case of Inappropriate schedule of product administration for mRNA-1273 (lot # unknown), with no associated AEs. Further information has been requested.
Narrative: COVID infection following COVID vaccine series 03/16, Pfizer, dose #1 04/08, Pfizer, dose #2 08/19 pt cc: cough, fatigue, headache, loss of taste or smell, myalgias, dyspena, exposure: unknown 08/25 COVID swab, result: detected 08/25 SARS-COV-2 Variant Sequencing result; pending
Patient received vaccine on 10/21/19. She called the pharmacy on 11/29/19 stating that the injection caused pain and she experienced a rash and swelling. Currently (38 days later) the rash is gone but she is still has swelling and pain.
Headache, Myalgia, Fatigue, Palpitations, HTN. Narrative:
Within a month or so after receiving my third dose of Pfizer I began to notice that I was feeling extremely exhausted. Around the 15th of November of that same year (2021) I began taking a thyroid medication and I received my third dose of Pfizer on 11/20/2021. On 03/16/2022 I saw a doctor for my fatigue. He advised that I do a sleep apnea sleep study which I did in May of 2022. I began to use a C-PAP machine in June of 2022 but I am still feeling extreme exhaustion to the point where I am very fatigued after menial tasks like moving pillows from my bed or moving dishes around in the dish washer. I am scheduled to see my doctor again next week, 08/04/2022, to discuss this further. Since receiving my third dose in 2021, I have also received a fourth dose of Pfizer on 04/20/2022.
Pt is experiencing a dull pain infrequently with movement. Pt received vaccine on 9/22 and came to the pharmacy 12/8 explaining her concern.
The vial was initially stored in refrigerator on 30-Jan-2023 (BUD 01-Mar-2023) and was adminitered on 02-Mar-2023; No adverse event; Patient had dose administered after 30-day Use By Date or after manufacturer date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient had dose administered after 30-day Use By Date or after manufacturer date), PRODUCT STORAGE ERROR (The vial was initially stored in refrigerator on 30-Jan-2023 (BUD 01-Mar-2023) and was adminitered on 02-Mar-2023) and NO ADVERSE EVENT (No adverse event) in a 58-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 045H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 02-Mar-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 02-Mar-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient had dose administered after 30-day Use By Date or after manufacturer date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in refrigerator on 30-Jan-2023 (BUD 01-Mar-2023) and was adminitered on 02-Mar-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient had dose administered after 30-day Use By Date or after manufacturer date), PRODUCT STORAGE ERROR (The vial was initially stored in refrigerator on 30-Jan-2023 (BUD 01-Mar-2023) and was adminitered on 02-Mar-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient had dose administered after 30-day Use By Date or after manufacturer date) and PRODUCT STORAGE ERROR (The vial was initially stored in refrigerator on 30-Jan-2023 (BUD 01-Mar-2023) and was adminitered on 02-Mar-2023).    No concomitant medications were reported. Dosage text was reported as unknown. It was reported that 5  bivalent vial of unknown size was administered to 5 patients after 30 days use by date. The vial never underwent any temperature excursions. No adverse reaction was reported by patient at that time.  No treatment information was reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-714731, US-MODERNATX, INC.-MOD-2023-714729 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-714731:Same reporter US-MODERNATX, INC.-MOD-2023-714729:Same reporter
Information has been received from a registered nurse referring to an unknown number of patients of unknown age and gender. The patient's medical history and concurrent condition were not provided. On unspecified dates the patients were vaccinated with VAQTA (dosage, strength, route and lot # were not reported), which had been improperly stored. At the time of the report, no adverse effects were reported. This is one of several report from the same reporter. Additional information is not expected as the reporter did not wish further contact.
c/o not being able to move left arm, had extreme pain for two weeks post vaccination, went to the Dr. on 1/25 because the pain would not go away.
pt given the adult covid Pfizer vaccine by mistake, instead of receiving pediatric vaccine. MD notified. Pharmacist followed up 11/30 6:45 pm & parent reported pt doing okay, "feeling warm"
Chills, fever, body ache, headache, sore at injection site. Lasted for several hours through the night. Better in the morning but lingering fatigue for 24 hours.
After bending to pick something off the floor became extremely dizzy. I laid down on my left side and it slowed down, but every time I got up it continued. I made my way to the bed. Lying on my left side I was able to slow down the spinning feeling. I vomited about an hour later. I slept through the night, and although the spinning sensation stopped I felt weak all day. Two weeks later I am still having mild dizziness when I move my head quickly.
POSSIBLE ANAPHYLAXIS, DIFFICULTY SWALLOWING, BREATHING, THEN SPEAKING. 911 CALLED. TRANSPORTED VIA EMS
Patient received DTaP #4, HIB #4, Pneumococcal #4 and Hep A #2 on 5-13-11 (morning). Early 5-14-11 he had a prolonged seizure lasting about 20 minutes. Associated with fever 102.0 (F). Questionable febrile seizure vs. other etiology.
high fever, chills, vertigo, nausea, muscle pain and headache lasted three days. Severe fatigue. Unable to work. Took ibuprofen and hydrated.
10FEB98 noticed pain, redness & swelling @ site of inj rt arm;14FEB98 inc sx ER visit-placed on oral ATB for cellulitis;17FEB98 hosp until 26FEB98 w/cellulitis;7MAR98 readmitted & placed on IV med;
This spontaneous report as received from a pharmacist who was informed by a patient of unknown age and gender. On an unknown date, the patient was vaccinated with a dose of PNEUMOVAX 23 (lot #, expiration date and route were not provided). On an unknown date, the patient developed soreness at the injection site as well as redness at the injection site that went down the patient's arm after receiving PNEUMOVAX 23. It was unknown if the patient sought medical attention. At the time of the report, the patient's status was unknown. This is one of several reports received from the same source. Additional information has been requested.
Swelling of tongue and throat; Swelling of tongue and throat; Would not take second shot of vaccine; This spontaneous case was reported by a consumer and describes the occurrence of SWOLLEN TONGUE (Swelling of tongue and throat), THROAT TIGHTNESS (Swelling of tongue and throat) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Would not take second shot of vaccine) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to animals (Allergy to dogs), Allergy to animals (Allergy to cats) and Dust allergy.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced SWOLLEN TONGUE (Swelling of tongue and throat), THROAT TIGHTNESS (Swelling of tongue and throat) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Would not take second shot of vaccine). On 18-Mar-2021, SWOLLEN TONGUE (Swelling of tongue and throat), THROAT TIGHTNESS (Swelling of tongue and throat) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Would not take second shot of vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided. concomitant medicines was not reported by reporter   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  The patient had taken first shot t 10' clock in the after noon,swelling of tongue and throat  had developed at night 10' clock ,went to the hospital on the same day and waited 45 min to an hour until the symptoms went away.   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.. No further information is expected at this time as patient wanted to remain anonymous.
This spontaneous report was received from a pharmacist refers to a patient of unknown age and gender. On an unknown date, the patient was vaccinated with a dose of PNEUMOVAX 23 (lot # and route not reported). No concomitant medications were reported. On an unknown date, the patient experienced an unspecified allergic reaction to PNEUMOVAX 23. It was unspecified if the patient had sought medical attention. The outcome of the event was unknown. Additional information has been requested.
pt recvd vax 29JUN93 & 8JUL93 t102.5, rash over chest, face, back & upper arms; refuses food;
A report received on 10/25/02, concerning a 33 year old female vaccinee and approximately 15 clinic staff members who were inadvertently administered Fluvirin in error in 10/2002. The reporter suspected that the staff members may have received the vaccine subcutaneously and not intramuscularly. No adverse effects were reported. The reporter has assessed the relationship of the vaccines to the event as unclassifiable. A report received from a health professional on 10/13/2002, indicated that 7 vaccinees were administered Fluvirin subcutaneously on 10/08/02. The outcome of the event was reported as unknown. Ref: PJP200200890, PJP200200882, PJP200200883, PJP200200885 and PJP200200889.
A report has been received from a Health Professional concerning a Child, Male subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST started on an unknown date. The licensed practical nurse reported that fifteen days expired FLUMIST QUADRIVALENT was given to two patients. Neither patient has reported any adverse event symptoms. The outcome of the event gave FLUMIST QUADRIVALENT that was 15 days expired is unknown. The report was considered to be non-serious by reporter.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 15Aug2021 at 11:30 as dose 3 (booster), single (Lot number: FC3181), in left arm, on 02Mar2022 at 13:00 as dose 4 (booster), single (Lot number: FJ6369), in left arm and on 03Jul2022 at 11:00 as dose 5 (booster), single (Lot number: FM0173) at the age of 62 years, in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 30Mar2022 at 08:45 as dose 1, single (Lot number: 020B21A), in left arm and on 27Apr2022 at 11:00 as dose 2, single (Lot number: 09C21A), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Crohn's disease" (unspecified if ongoing); "Interchange of vaccine products" (unspecified if ongoing). Concomitant medication(s) included: CITRACAL [CALCIUM CITRATE], start date: May2020, stop date: 14Jul2022; OMEPRAZOLE, start date: Jan2021, stop date: 14Jul2022; B-12 NATURE MADE, start date: May2020, stop date: 14Jul2022; ACETAMINOPHEN, start date: 13Jul2022, stop date: 13Jul2022; IRON, start date: May2020, stop date: 14Jul2022. Past drug history included: Ampicillin, reaction(s): "known allergies: Allergic to ampicillin", notes: known allergies: Allergic to ampicillin; Vicodin, reaction(s): "known allergies: vicodin", notes: known allergies: vicodin. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: unknown results, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, suspected covid-19.  No follow-up attempts are possible. No further information is expected.
MOP noticed HIVES all over trunk of body.  ARNP available to see child and oral Benadryl administered.  Child remained in clinic another hour.  Remained otherwise stable without any other symptoms.  Released to home.  Follow up call - recovered from hives quickly that evening.
527 patients were immunized with Pfizer COVID-19 vaccine that was stored at out of range temperatures.  After discussing with Pfizer, we are in the process of reimmunizing the patients.  No adverse reactions reported just reporting the storage error.  Please feel free to contact me if you have any questions.
Hands swollen like a balloon; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Hands swollen like a balloon) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PERIPHERAL SWELLING (Hands swollen like a balloon). At the time of the report, PERIPHERAL SWELLING (Hands swollen like a balloon) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Ultrasound scan: (Inconclusive) could not find anything wrong. On an unknown date, X-ray: (Inconclusive) could not find anything wrong.         Treatment details included Pain medication.
Was seen on 2/9/18  in office after immunization given on 2/8/18 and reported hives, facial swelling of lips, eyes, cough within 20 min of immunization given in office; was taken to ER and received IV steroid and Benadryl.